These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2934334)

  • 1. The differential impact of copayment on drug use in a Medicaid population.
    Reeder CE; Nelson AA
    Inquiry; 1985; 22(4):396-403. PubMed ID: 2934334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.
    Nelson AA; Reeder CE; Dickson WM
    Med Care; 1984 Aug; 22(8):724-36. PubMed ID: 6433121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copayment for pharmaceutical services in a Medicaid program.
    Nelson AA; Quick MR
    Contemp Pharm Pract; 1980; 3(1):37-42. PubMed ID: 10297666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
    Kostova D; Fox J
    Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effect of newer medication adoption in an older Medicaid cohort.
    Shireman TI; Rigler SK; Jachna CM; Griebling TL; Eng ML
    J Am Geriatr Soc; 2005 Aug; 53(8):1366-73. PubMed ID: 16078963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH; Kautter J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Medicaid copayments on patients with cancer: lessons for Medicaid expansion under health reform.
    Subramanian S
    Med Care; 2011 Sep; 49(9):842-7. PubMed ID: 21577164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to trends in prescription drug expenditures.
    Suh DC; Lacy CR; Barone JA; Moylan D; Kostis JB
    Clin Ther; 1999 Jul; 21(7):1241-53. PubMed ID: 10463521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 15. Unintended consequences of a Medicaid prescription copayment policy.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    Med Care; 2014 May; 52(5):422-7. PubMed ID: 24686394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment.
    Martikainen JE; Häkkinen U; Enlund H
    Clin Ther; 2007 Nov; 29(11):2468-76. PubMed ID: 18158088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid expenditures and utilization in the Medicaid system.
    Brixner DI; Oderda GM; Roland CL; Rublee DA
    J Pain Palliat Care Pharmacother; 2006; 20(1):5-13. PubMed ID: 16687350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.